Amgen launches 2020 LabCentral Golden Ticket competition for innovative life science startups, awarding two startups with with lab space, amenities, and services.
A leading pharmaceutical company in Amyotrophic Lateral Sclerosis (ALS) is interested in speaking with startups whose technology could contribute to very early diagnosis of the disease.
Looking for 6 startups to present their tech on March 31 and April 1 (KST) / March 30 and March 31 (ET) at the Virtual 2022 KPBMA-MIT Life Science Conference.
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Vincent Ling, Senior Director, Materials and Innovation, Takeda